Catheter Ablation for Atrial Fibrillation in Non-Fluoroscopic Lab

NANot yet recruitingINTERVENTIONAL
Enrollment

724

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

January 31, 2028

Study Completion Date

May 31, 2028

Conditions
Atrial Fibrillation (AF)
Interventions
PROCEDURE

AF ablation

"The primary ablation strategy for both groups will be pulmonary vein isolation (PVI).~Other additional ablation, including but not limited to linear ablation, complex fractionated atrial electrogram (CFAE) ablation, or superior vena cava (SVC) isolation is not recommended unless necessitated by one of the following:~* Documented atrial flutter (AFL) or atrial tachycardia (AT) observed during the procedure, or~* Arrhythmias originating from the specific region requiring intervention."

OTHER

AF ablation in a non-fluoroscopic EP lab

This procedure will take place in a non-fluoroscopic lab.

OTHER

AF ablation in a fluoroscopic lab

This procedure will take place in a fluoroscopic lab.

Trial Locations (1)

310000

Sir Run Run Shaw Hospital, Hangzhou

All Listed Sponsors
lead

Sir Run Run Shaw Hospital

OTHER

NCT06719921 - Catheter Ablation for Atrial Fibrillation in Non-Fluoroscopic Lab | Biotech Hunter | Biotech Hunter